Daniella Mehalik
Financieel Directeur/CFO bij PSYCHEMEDICS CORPORATION
Actieve functies van Daniella Mehalik
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PSYCHEMEDICS CORPORATION | Financieel Directeur/CFO | 27-11-2023 | - |
| Investor Relations Contact | - | - | |
| Treasurer | 27-11-2023 | - |
Loopbaan van Daniella Mehalik
Eerdere bekende functies van Daniella Mehalik
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NEUBASE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-01-2021 | 01-01-2023 |
| DxTx Medical, Inc. | Comptroller/Controller/Auditor | 01-01-2019 | 01-01-2021 |
Opleiding van Daniella Mehalik
| Carlow University Of | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Investor Relations Contact | 1 |
Sectoraal
| Health Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PSYCHEMEDICS CORPORATION | Health Services |
| Bedrijven in privébezit | 2 |
|---|---|
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on August 4, 2009 and is headquartered in Pittsburgh, PA. | Health Technology |
| DxTx Medical, Inc. |
- Beurs
- Insiders
- Daniella Mehalik
- Ervaring
